Akeso Announces Completion of Patient Enrollment in The Phase III Clinical Trial of Cadonilimab for Adjuvant Treatment of High-Risk Recurrent Hepatocellular Carcinoma
HONG KONG, March 5, 2025 /PRNewswire/ — Akeso, Inc. (9926. HK) (“Akeso” or the “Company”) is pleased to announce the completion of patient enrollment for its Phase III registrational clinical trial (COMPASSION-22/AK104-306) evaluating cadonilimab, the world’s firs
NEW ORLEANS’ VFW CENTER RECEIVES RESILIENT SOLAR POWER THANKS TO GULF COAST ENERGY FIRMS POSIGEN AND SOLAR ALTERNATIVES AND NONPROFIT EMPOWERED BY LIGHT
NEW ORLEANS, March 5, 2025 /PRNewswire/ — Regional energy firms PosiGen, PBC, and Solar Alternatives joined forces with the renewable energy-focused nonprofit, Empowered by Light, to install solar and energy storage at New Orleans’ only Veterans of Foreign Wars (VFW) facility at 531 Lyo
CStone Submits Clinical Trial Application in Australia for CS5001 (ROR1 ADC) in Combination with First-Line Standard-of-Care for DLBCL
Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming to reshape the standard-of-care landscape. CS5001 is also being investigated globally in a multi-center Phase Ib clinical trial for multiple solid tumor types. S
Realtor® Association Recommends Projects to Maximize Home Value for a Sale
HARRISBURG, Pa., March 5, 2025 /PRNewswire/ — As the spring thaw arrives, homeowners considering selling their property are encouraged to take advantage of warmer weather to enhance their home’s appeal and marketability. According to the Pennsylvania Association of Realtors®, spring hom
Canada Invests in the Next Generation of Canadian-Made, Clean, Affordable Nuclear Energy
CAMBRIDGE, ON, March 5, 2025 /CNW/ – Nuclear energy plays a pivotal role in the Canadian energy supply, contributing vital non-emitting electricity to the grid in Canada. That’s why the Government of Canada has been making strategic investments in nuclear energy at a time when there is
Apollo Group TV Expands Payment Options Making Premium Streaming More Accessible with Raydium Solutions
BOSTON, March 5, 2025 /PRNewswire/ — In a strategic partnership with Raydium Solutions, Apollo Group TV is making premium streaming more accessible by introducing credit card payments for the first time. Previously limited to Bitcoin transactions, this major shift allows more users to enjoy se
Brookdale Confirms Receipt of Director Nominations
No Shareholder Action Required at this Time NASHVILLE, Tenn., March 5, 2025 /PRNewswire/ — Brookdale Senior Living Inc. (NYSE: BKD) (“Brookdale” or the “Company”) today confirmed that it has received notice from Pangaea Ventures, L.P., a fund managed by Ortelius Advisor
Anti-Obesity Drugs Benefit Kidney Transplant Recipients with Type 2 Diabetes
-Drugs found to be safe and effective overall despite some risk of eye damage NEW YORK, March 5, 2025 /PRNewswire/ — Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study sh
California’s New Pre-Kindergarten through Third Grade Teaching Credential Programs Aim to Address Teacher Shortage, Provide Specialized Early Learner Instruction
SACRAMENTO, Calif., March 5, 2025 /PRNewswire/ — The California Commission on Teacher Credentialing continues to approve a growing number of teaching credential programs for those who want to instruct and inspire the state’s youngest learners in pre-kindergarten through third grade (PK-3
Press Freedom Program Focuses On Deadly Tank Attack On Journalists From Reuters, AFP, Al Jazeera
WASHINGTON, March 5, 2025 /PRNewswire/ — News Advisory: Event: Program to analyze Oct 13, 2023 attack on journalists from Reuters, Agence France Press and Al Jazeera When: 6:30 p.m., Wednesday, March 12 (Doors Open at 6 p.m.) Where: Ballroom, National Press Club, 529 14th Street NW, 13th Floor
